Literature DB >> 21717985

Use of vacuum-assisted closure in pediatric open fractures with a focus on the rate of infection.

Jason Halvorson1, Riyaz Jinnah, Brenda Kulp, John Frino.   

Abstract

The use of the vacuum-assisted closure device (VAC; KCI, San Antonio, Texas) has given the orthopedist a new tool for the successful management of severe traumatic wounds and open fractures. While the VAC's role in the adult population is proving itself as an improved therapy compared to "traditional wound care," it's role within pediatric orthopedics remains less well defined. Questions remain whether VAC therapy provides benefit regarding decreased infection rates as well as decreased need for extensive soft tissue coverage procedures. A review was therefore performed of a pediatric level I trauma center's experience using the VAC therapy for pediatric open fractures with a focus on the rate of superficial, deep, and chronic infection. A retrospective chart review spanning 4.5 years of all pediatric patients younger than 18 years with an open fracture initially treated with VAC therapy was conducted at a level I pediatric trauma center. This yielded 28 patients with 37 open fractures aged 2 to 17 years who were initially treated with wound VAC therapy. Subsequent chart review of these patients was performed examining in-hospital records, operative notes, and clinical follow-up visits for documented cases of superficial, deep, or chronic infection. Of 37 open pediatric fractures treated with a wound VAC, there were no cases of superficial infection and 2 cases of deep infection for an overall infection rate of 5%. Both infections resolved with surgical intervention and antibiotics without chronic infection development. When compared with historical controls, the use of VAC therapy for pediatric open fractures appears to be an equally safe and effective modality to help reduce infection in pediatric open fractures and should be considered a valuable tool in treating these injuries. Copyright 2011, SLACK Incorporated.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21717985     DOI: 10.3928/01477447-20110526-15

Source DB:  PubMed          Journal:  Orthopedics        ISSN: 0147-7447            Impact factor:   1.390


  7 in total

Review 1.  Management of Traumatic Wounds and a Novel Approach to Delivering Wound Care in Children.

Authors:  Kathryn Q Bernabe; Thomas J Desmarais; Martin S Keller
Journal:  Adv Wound Care (New Rochelle)       Date:  2014-04-01       Impact factor: 4.730

Review 2.  Negative-Pressure Wound Therapy in Infants and Children: A Population-Based Study.

Authors:  Katherine B Santosa; Matt Keller; Margaret A Olsen; Alexandra M Keane; Erika D Sears; Alison K Snyder-Warwick
Journal:  J Surg Res       Date:  2018-11-30       Impact factor: 2.192

3.  Results of vacuum assisted wound closure application.

Authors:  Tolga Atay; Halil Burc; Yakup Barbaros Baykal; Vecihi Kirdemir
Journal:  Indian J Surg       Date:  2012-04-19       Impact factor: 0.656

4.  The evidence-based principles of negative pressure wound therapy in trauma & orthopedics.

Authors:  Novak A; Wasim S Khan; Palmer J
Journal:  Open Orthop J       Date:  2014-06-27

5.  Pediatric Open Long-Bone Fracture and Subsequent Deep Infection Risk: The Importance of Early Hospital Care.

Authors:  Andrew W Kuhn; Stockton C Troyer; Jeffrey E Martus
Journal:  Children (Basel)       Date:  2022-08-17

6.  In-hospital low-cost custom made VAC: Effective method for reducing infection in late presenting Open lower limb fractures in overburdened Indian hospitals.

Authors:  Towseef Ahmad Bhat; Rouf Ibrahim; Tariq Ahmad Bhat; Aejaz Ahmad Bhat
Journal:  J Clin Orthop Trauma       Date:  2017-11-24

7.  Free dermatoplasty combined with vacuum sealing drainage for the treatment of large-area soft tissue defects accompanied by bone exposure in the lower leg.

Authors:  Jiafu Qu; Rongliang Yan; Liang Wang; Jun Wu; Lihai Cao; Guozhi Zhao; Kaiyan Sun; Ling Zhang; Xiaojian DU; Yi Peng; Shaoguang Li; Haidong Ma; Jianhua Gao; Hongda Liu
Journal:  Exp Ther Med       Date:  2013-03-12       Impact factor: 2.447

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.